Aurobindo Pharma's Q4 profit shrinks

Blog | Morning Update

Good morning!

Here are the top stories to start your day.

Aurobindo Pharma's Q4 profit shrinks

Aurobindo Pharma (+1.8%) reported a drop of 12.2% in net profit to ₹505.9 crore in Q4FY23 from ₹576.1 crore in the comparable quarter last year. In the same period, its revenue from operations grew by 11.4% YoY to ₹6,473 crore. The company said it witnessed a decent performance in the current quarter driven by stable demand and pricing environment across its portfolio and geographies.

JK Cement's profit drops

JK Cement (+1.8%) reported a net profit of ₹112.26 crore in Q4FY23, a drop of 44% compared to ₹201.12 crore posted in the same period last year. However, its net consolidated total income for the quarter grew 17.7% YoY at ₹2,815.84 crore from ₹2,392.28 crore last year. The company's board has recommended a dividend of ₹15 per share.

Indigo Paints reports robust profit growth

Indigo Paints (+2.6%) reported a profit of ₹48.68 crore for Q4FY23, a growth of 40.7 % YoY from ₹34.59 crore posted last year. Its revenue from operations for the quarter stood at ₹325.47 crore, up 12.8% from ₹288.38 crore reported in the corresponding quarter of last year. The company's board has recommended a final dividend of ₹3.50.

 


Global markets (at 8:45 AM today)

Indices Today's movement
SGX Nifty ▲ 0.8 % 
Nikkei 225 (Japan) 1.3%
Hang Seng (Hong Kong) ▼ 0.4%
SSE Composite (China) ▲ 0.0%
Dow Jones (US) (May 27) ▲ 1.0 %
NYSE (US) (May 27) ▲ 0.6%
Nasdaq (US) May 27) 2.1%
S&P 500 (US) (May 27) 1.3%

Fact of the day

Banks reported lowest bad loan provisioning in Q4, since the pandemic

Source: Economic Times

Download IconDownload the Upstox App Today